Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia

The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells

(2011) Fu-Ning Hsu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Understanding the "lethal" drivers of tumor-stroma co-evolution

(2010) Michael P. Lisanti et al.   CANCER BIOLOGY & THERAPY

Effect of the hsp90 inhibitor geldanamycin on androgen response of prostate cancer under hypoxic conditions

(2010) Yasutomo Suzuki et al.   INTERNATIONAL JOURNAL OF UROLOGY

Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes

(2009) R. M. Attar et al.   CLINICAL CANCER RESEARCH

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

(2009) Todd Morgan et al.   CURRENT CANCER DRUG TARGETS

Targeted Overexpression of Vav3 Oncogene in Prostatic Epithelium Induces Nonbacterial Prostatitis and Prostate Cancer

(2008) Y. Liu et al.   CANCER RESEARCH

Androgen receptor and growth factor signaling cross-talk in prostate cancer cells

(2008) M.-L. Zhu et al.   ENDOCRINE-RELATED CANCER

Progress in Understanding Androgen-Independent Prostate Cancer (AIPC): A Review of Potential Endocrine-Mediated Mechanisms

(2008) Fritz H. Schröder   EUROPEAN UROLOGY

Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype

(2008) Karl T. Butterworth et al.   INTERNATIONAL JOURNAL OF CANCER